Matches in Wikidata for { <http://www.wikidata.org/entity/Q45950518> ?p ?o ?g. }
- Q45950518 description "2014 nî lūn-bûn" @default.
- Q45950518 description "2014 թվականի նոյեմբերի 6-ին հրատարակված գիտական հոդված" @default.
- Q45950518 description "2014年の論文" @default.
- Q45950518 description "2014年学术文章" @default.
- Q45950518 description "2014年学术文章" @default.
- Q45950518 description "2014年学术文章" @default.
- Q45950518 description "2014年学术文章" @default.
- Q45950518 description "2014年学术文章" @default.
- Q45950518 description "2014年学术文章" @default.
- Q45950518 description "2014年學術文章" @default.
- Q45950518 description "2014年學術文章" @default.
- Q45950518 description "2014年學術文章" @default.
- Q45950518 description "2014年學術文章" @default.
- Q45950518 description "2014年學術文章" @default.
- Q45950518 description "2014년 논문" @default.
- Q45950518 description "article científic" @default.
- Q45950518 description "article scientific" @default.
- Q45950518 description "article scientifique" @default.
- Q45950518 description "articol științific" @default.
- Q45950518 description "articolo scientifico" @default.
- Q45950518 description "artigo científico" @default.
- Q45950518 description "artigo científico" @default.
- Q45950518 description "artigo científico" @default.
- Q45950518 description "artikel ilmiah" @default.
- Q45950518 description "artikull shkencor" @default.
- Q45950518 description "artikulong pang-agham" @default.
- Q45950518 description "artykuł naukowy" @default.
- Q45950518 description "artículo científico publicado en 2014" @default.
- Q45950518 description "artículu científicu" @default.
- Q45950518 description "bilimsel makale" @default.
- Q45950518 description "bài báo khoa học" @default.
- Q45950518 description "naučni članak" @default.
- Q45950518 description "scienca artikolo" @default.
- Q45950518 description "scientific article published on 6 November 2014" @default.
- Q45950518 description "scientific article published on 6 November 2014" @default.
- Q45950518 description "scientific article published on 6 November 2014" @default.
- Q45950518 description "teaduslik artikkel" @default.
- Q45950518 description "tieteellinen artikkeli" @default.
- Q45950518 description "tudományos cikk" @default.
- Q45950518 description "vedecký článok" @default.
- Q45950518 description "vetenskaplig artikel" @default.
- Q45950518 description "videnskabelig artikel" @default.
- Q45950518 description "vitenskapelig artikkel" @default.
- Q45950518 description "vitskapeleg artikkel" @default.
- Q45950518 description "vědecký článek" @default.
- Q45950518 description "wetenschappelijk artikel" @default.
- Q45950518 description "wissenschaftlicher Artikel" @default.
- Q45950518 description "επιστημονικό άρθρο" @default.
- Q45950518 description "мақолаи илмӣ" @default.
- Q45950518 description "наукова стаття, опублікована в листопаді 2014" @default.
- Q45950518 description "научна статия" @default.
- Q45950518 description "научная статья" @default.
- Q45950518 description "научни чланак" @default.
- Q45950518 description "научни чланак" @default.
- Q45950518 description "מאמר מדעי" @default.
- Q45950518 description "مقالة علمية نشرت في 6 نوفمبر 2014" @default.
- Q45950518 description "৬ নভেম্বর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45950518 description "บทความทางวิทยาศาสตร์" @default.
- Q45950518 description "სამეცნიერო სტატია" @default.
- Q45950518 name "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 name "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 type Item @default.
- Q45950518 label "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 label "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 prefLabel "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 prefLabel "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 P1433 Q45950518-1B0555BA-8199-4DE6-91BB-02F9B36DB9D9 @default.
- Q45950518 P1476 Q45950518-06FE9251-6B04-49CF-9A5A-F79C171F9BF4 @default.
- Q45950518 P2093 Q45950518-12602428-9B14-4A64-B179-B2ADB1AA0D30 @default.
- Q45950518 P2093 Q45950518-2196AA55-4159-4100-876E-1F2DF4AC7F98 @default.
- Q45950518 P2093 Q45950518-4224B6CF-1554-4C1D-AD3C-613218BAB507 @default.
- Q45950518 P2093 Q45950518-44387767-A4F1-40B3-91CB-8ADD3CC5F565 @default.
- Q45950518 P2093 Q45950518-59EA794D-C6B1-4D89-BEA3-CB0DC135C203 @default.
- Q45950518 P2093 Q45950518-7A303C9A-A689-4ACD-ABE3-40C36EAE7FDE @default.
- Q45950518 P2093 Q45950518-968A0ECE-682B-4334-8DF4-C39DAF01578F @default.
- Q45950518 P2093 Q45950518-AE86D882-958D-42AB-AB17-68DC367172A7 @default.
- Q45950518 P2093 Q45950518-BE17BCB9-00CF-42BE-B81C-2126DCBAC6C3 @default.
- Q45950518 P2093 Q45950518-E04B13BB-7A9A-4EE9-AAED-63C1AEDD9377 @default.
- Q45950518 P2888 Q45950518-CCDF0B23-9AC7-49AB-B971-668D6105EFC2 @default.
- Q45950518 P304 Q45950518-6D8B90D8-6A35-42B1-9B30-EDBE991F5239 @default.
- Q45950518 P31 Q45950518-F1E67343-45A8-4007-B931-E8DE67170C79 @default.
- Q45950518 P356 Q45950518-85A800CF-BB8A-4AC3-A4E9-E98D86C837C0 @default.
- Q45950518 P433 Q45950518-BA58CE97-8D24-4D1B-83C1-72F9F96E1639 @default.
- Q45950518 P478 Q45950518-E1DF97E8-359A-4C80-9582-376072A71CF0 @default.
- Q45950518 P577 Q45950518-D0815495-8734-4535-9043-95F4532C5D50 @default.
- Q45950518 P6179 Q45950518-ECD4CF78-5DBE-4582-AC8D-9C0D9E5E91A1 @default.
- Q45950518 P921 Q45950518-E464E312-BF03-404A-BB3B-A2A0F64C32C9 @default.
- Q45950518 P921 Q45950518-E519B830-E8F6-46C6-B9CC-EED1EEE851C4 @default.
- Q45950518 P932 Q45950518-80D35055-A43F-4F20-91E0-6A99556D5691 @default.
- Q45950518 P356 2051-1426-2-S3-P78 @default.
- Q45950518 P1433 Q27725163 @default.
- Q45950518 P1476 "Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02)." @default.
- Q45950518 P2093 "Bret Taback" @default.
- Q45950518 P2093 "Gregory Daniels" @default.
- Q45950518 P2093 "James Lowder" @default.
- Q45950518 P2093 "Lawrence Flaherty" @default.
- Q45950518 P2093 "Lee Cranmer" @default.
- Q45950518 P2093 "Mohammed Milhem" @default.
- Q45950518 P2093 "Sandra Aung" @default.
- Q45950518 P2093 "Sapna Patel" @default.